文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Liver cirrhosis and complications from the perspective of dysbiosis.

作者信息

Nie Guole, Zhang Honglong, Xie Danna, Yan Jun, Li Xun

机构信息

The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.

Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.

出版信息

Front Med (Lausanne). 2024 Jan 16;10:1320015. doi: 10.3389/fmed.2023.1320015. eCollection 2023.


DOI:10.3389/fmed.2023.1320015
PMID:38293307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10824916/
Abstract

The gut-liver axis refers to the intimate relationship and rigorous interaction between the gut and the liver. The intestinal barrier's integrity is critical for maintaining liver homeostasis. The liver operates as a second firewall in this interaction, limiting the movement of potentially dangerous compounds from the gut and, as a result, contributing in barrier management. An increasing amount of evidence shows that increased intestinal permeability and subsequent bacterial translocation play a role in liver damage development. The major pathogenic causes in cirrhotic individuals include poor intestinal permeability, nutrition, and intestinal flora dysbiosis. Portal hypertension promotes intestinal permeability and bacterial translocation in advanced liver disease, increasing liver damage. Bacterial dysbiosis is closely related to the development of cirrhosis and its related complications. This article describes the potential mechanisms of dysbiosis in liver cirrhosis and related complications, such as spontaneous bacterial peritonitis, hepatorenal syndrome, portal vein thrombosis, hepatic encephalopathy, and hepatocellular carcinoma, using dysbiosis of the intestinal flora as an entry point.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29b/10824916/d6211eac0e68/fmed-10-1320015-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29b/10824916/4c3d636abccc/fmed-10-1320015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29b/10824916/d6211eac0e68/fmed-10-1320015-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29b/10824916/4c3d636abccc/fmed-10-1320015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29b/10824916/d6211eac0e68/fmed-10-1320015-g002.jpg

相似文献

[1]
Liver cirrhosis and complications from the perspective of dysbiosis.

Front Med (Lausanne). 2024-1-16

[2]
Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation.

World J Gastroenterol. 2019-9-7

[3]
Targeting the gut-liver-immune axis to treat cirrhosis.

Gut. 2021-5

[4]
FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis.

J Hepatol. 2019-12

[5]
Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.

Hepatol Int. 2017-5-26

[6]
Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update.

Gut Liver. 2021-9-15

[7]
Intestinal permeability in a patient with liver cirrhosis.

Ther Clin Risk Manag. 2016-11-18

[8]
Gut microbiota-related complications in cirrhosis.

World J Gastroenterol. 2014-11-14

[9]
Gut-liver axis signaling in portal hypertension.

World J Gastroenterol. 2019-10-21

[10]
Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis.

Life (Basel). 2023-4-11

引用本文的文献

[1]
Portal vein thrombosis and Esophageal-Gastric variceal bleeding in cirrhosis: shared risk factors and causal relationship.

BMC Gastroenterol. 2025-7-5

[2]
New insights into the intestinal barrier through "gut-organ" axes and a glimpse of the microgravity's effects on intestinal barrier.

Front Physiol. 2024-10-10

[3]
Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine.

Front Pharmacol. 2024-7-16

本文引用的文献

[1]
Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications.

Front Cell Infect Microbiol. 2022

[2]
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.

Biomolecules. 2021-12-31

[3]
Liver cirrhosis.

Lancet. 2021-10-9

[4]
Fetal meconium does not have a detectable microbiota before birth.

Nat Microbiol. 2021-7

[5]
Gut microbiota modulates the inflammatory response and cognitive impairment induced by sleep deprivation.

Mol Psychiatry. 2021-11

[6]
Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome.

Microbiome. 2021-5-6

[7]
A Systematic Review of Dietary Influences on Fecal Microbiota Composition and Function among Healthy Humans 1-20 Years of Age.

Adv Nutr. 2021-10-1

[8]
Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai).

J Dig Dis. 2021-4

[9]
Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review.

Nutrients. 2021-1-3

[10]
Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease.

Thromb Res. 2021-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索